The exchange a company lists on is not a cosmetic choice. It sets the floor on who can find the stock, who is allowed to own it, and how the market reads its credibility. Here is how the three tiers compare.
OTCQB is a venture tier on the OTC dealer network, with the lowest bar to entry. The Nasdaq Capital Market and NYSE American are national exchanges, with higher standards and broader institutional access. Moving up expands who can own the stock and how it is perceived, at the cost of stricter requirements and higher compliance overhead. Note that listing standards tightened in 2025, with new rules aimed at curbing reliance on reverse stock splits. And note one thing that does not change with tier: a national listing does not create analyst coverage. That gap exists at every level.
OTCQB sits on the OTC Markets system, a decentralized dealer network rather than a formal exchange. It is built for earlier-stage, growth companies that are current in their reporting but not yet ready for a national exchange. The Nasdaq Capital Market and NYSE American are national securities exchanges, with the higher financial, governance, and disclosure standards that national listing implies. The practical difference is who is on the other side of the door: a national exchange opens access to institutions, index and ETF inclusion, and a level of credibility the OTC tier does not confer.
The figures below are representative initial-listing requirements. Each exchange maintains several alternative qualification standards, and the rules change, so treat this as orientation and verify current requirements with counsel before acting.
| Dimension | OTCQB | Nasdaq Capital Market | NYSE American |
|---|---|---|---|
| Type | OTC dealer network | National exchange | National exchange |
| Min. bid price (initial) | About $0.01 | About $4 | About $2 to $3 |
| Holders | ~50 beneficial | ~300 round-lot | ~400 |
| Public float / market value | Lower bar | ~$15M public float value | ~$3M public float value |
| Reporting & governance | Current reporting, audited financials | Full SEC reporting, exchange governance | Full SEC reporting, exchange governance |
| Indicative annual fee | ~$15,000 | Higher | Higher |
| Institutional access | Limited | Broad; ETF and index eligible | Broad; ETF and index eligible |
One number worth separating: the roughly $4 minimum bid for Nasdaq and the $2 to $3 range for NYSE American are initial-listing thresholds. Once listed, the continued-listing minimum bid is generally $1.00, and falling below it for a sustained period is what triggers a deficiency notice and the clock toward delisting.
The reason companies climb is access, not vanity. A national exchange listing makes a stock eligible for the large pools of capital, index funds, many institutional mandates, and ETFs, that are structurally barred from most OTC names. It tightens credibility with investors and counterparties. And it tends to correlate with deeper liquidity, because a wider universe of permitted owners produces more two-sided trading. OTCQB, in exchange for a far lower bar and lower cost, offers less of all three. For many companies it is the right place to be while building toward a national listing, not a permanent home.
Both national exchanges have been tightening. In January 2025, the SEC approved amendments to the minimum-price and delisting rules for Nasdaq and the NYSE, designed to limit companies' reliance on reverse stock splits to stay compliant and to enforce deficiencies more firmly. Later in 2025, Nasdaq proposed further changes, including higher public-float and capital-raised thresholds and faster delisting procedures for the smallest companies. The direction is consistent: the national exchanges are raising the bar at the bottom, which makes the gap between a clean OTCQB company and a listing-ready one more consequential than it was a few years ago.
Here is the part that catches companies by surprise. Moving to a national exchange expands who can own the stock, but it does not, by itself, produce analyst research or investor attention. Plenty of Nasdaq and NYSE American companies have no meaningful sell-side coverage at all, for the same economic reasons covered in why analysts do not cover small-cap stocks. The listing solves eligibility. It does not solve visibility. Those are two different problems, and a company that uplists expecting coverage to follow is often disappointed. Closing the coverage gap is separate work, and it is the same work whether a company trades on OTCQB or Nasdaq.
OTCQB is a venture tier on the OTC dealer network with the lowest entry bar, suited to earlier-stage companies that are current in their reporting. The Nasdaq Capital Market and NYSE American are national securities exchanges with higher financial and governance standards and far broader institutional access, including eligibility for index funds and ETFs.
Representative initial-listing requirements include a minimum bid price around $4, at least roughly 300 round-lot holders, public float value around $15M under one standard, and full SEC reporting with exchange governance. Several alternative standards exist and the rules change. The continued-listing minimum bid is generally $1.00.
Because the listing tier sets the floor on who can find and own the stock. A national exchange opens access to institutions, index funds, and ETFs that are barred from most OTC names, adds credibility, and tends to correlate with deeper liquidity. OTCQB offers a lower bar and lower cost but less institutional access.
No. Uplisting expands who is allowed to own the stock, but it does not by itself produce analyst research. Many national-exchange small-caps have no meaningful coverage for the same economic reasons that affect OTC companies. Listing solves eligibility; visibility and coverage are a separate problem that exists at every tier.
Whatever tier a company trades on, the coverage gap is the same problem. Watchlist Wire produces permanent, disclosed research on qualified micro-cap companies on the Nasdaq Capital Market, NYSE American, and OTCQB. Submit a company for a coverage eligibility review.
Institutional Partnership → See the research library